Correlation Between Infinity Pharmaceuticals and Brickell Biotech
Can any of the company-specific risk be diversified away by investing in both Infinity Pharmaceuticals and Brickell Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Infinity Pharmaceuticals and Brickell Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Infinity Pharmaceuticals and Brickell Biotech, you can compare the effects of market volatilities on Infinity Pharmaceuticals and Brickell Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Infinity Pharmaceuticals with a short position of Brickell Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Infinity Pharmaceuticals and Brickell Biotech.
Diversification Opportunities for Infinity Pharmaceuticals and Brickell Biotech
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Infinity and Brickell is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Infinity Pharmaceuticals and Brickell Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brickell Biotech and Infinity Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Infinity Pharmaceuticals are associated (or correlated) with Brickell Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brickell Biotech has no effect on the direction of Infinity Pharmaceuticals i.e., Infinity Pharmaceuticals and Brickell Biotech go up and down completely randomly.
Pair Corralation between Infinity Pharmaceuticals and Brickell Biotech
Given the investment horizon of 90 days Infinity Pharmaceuticals is expected to under-perform the Brickell Biotech. In addition to that, Infinity Pharmaceuticals is 1.36 times more volatile than Brickell Biotech. It trades about -0.04 of its total potential returns per unit of risk. Brickell Biotech is currently generating about -0.04 per unit of volatility. If you would invest 1,039 in Brickell Biotech on January 26, 2024 and sell it today you would lose (949.00) from holding Brickell Biotech or give up 91.34% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 69.31% |
Values | Daily Returns |
Infinity Pharmaceuticals vs. Brickell Biotech
Performance |
Timeline |
Infinity Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Brickell Biotech |
Infinity Pharmaceuticals and Brickell Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Infinity Pharmaceuticals and Brickell Biotech
The main advantage of trading using opposite Infinity Pharmaceuticals and Brickell Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Infinity Pharmaceuticals position performs unexpectedly, Brickell Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will offset losses from the drop in Brickell Biotech's long position.Infinity Pharmaceuticals vs. NextCure | Infinity Pharmaceuticals vs. Chimerix | Infinity Pharmaceuticals vs. Eledon Pharmaceuticals | Infinity Pharmaceuticals vs. CytomX Therapeutics |
Brickell Biotech vs. Terns Pharmaceuticals | Brickell Biotech vs. Amylyx Pharmaceuticals | Brickell Biotech vs. Acumen Pharmaceuticals | Brickell Biotech vs. Inozyme PharmaInc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Global Correlations Find global opportunities by holding instruments from different markets |